Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART
- PMID: 15206064
- DOI: 10.1086/421386
Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART
Abstract
Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection occurs commonly. The introduction of antiretroviral therapy can result in immune reconstitution hepatitis. We describe 2 coinfected patients who developed clinical flares of HBV disease, despite the inclusion of lamivudine, a drug with anti-HBV activity, in their HAART regimens. Potential strategies to manage individuals with HBV/HIV coinfection are discussed.
Comment in
-
What drives hepatitis B virus-related hepatic flares? Virus, T cells--or a bit of both?Clin Infect Dis. 2004 Jul 1;39(1):133-5. doi: 10.1086/421409. Epub 2004 Jun 1. Clin Infect Dis. 2004. PMID: 15206065 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
